Back to Journals » International Journal of Nanomedicine » Volume 19

Zinc Oxide Nanoparticles Induce Toxic Responses in Human Neuroblastoma SH-SY5Y Cells in a Size-Dependent Manner [Corrigendum]

Authors Liu J, Kang Y, Yin S, Song B, Wei L, Chen L, Shao L 

Received 6 August 2024

Accepted for publication 6 August 2024

Published 8 August 2024 Volume 2024:19 Pages 8115—8116

DOI https://doi.org/10.2147/IJN.S490271



Liu J, Kang Y, Yin S, et al. Int J Nanomedicine. 2017;12:8085–8099.

The authors have advised the control images for Figure 4A and B were the same to represent the one and the same control group. To alleviate any potential confusion this may have created, the authors have provided a corrected Figure 4. This correction does not change the scientific conclusions of the article in any way.

Figure 4 Confocal microscopy investigation of the cellular distribution of lysosomes and zinc ions in SH-SY5Y cells after the two types of ZnO NP treatments.

Abbreviation: NP, nanoparticle.

Notes: After the SH-SY5Y cells were untreated (the Control group) or treated with the ZnOa NPs and ZnOb NPs (50 µg/mL) for 1 h, 3 h, or 5 h, the cells were loaded with FluoZin3 (green), LysoTracker (red) and Hoechst 33342 (blue). We observed almost no zinc ion fluorescence in the Control group, but significant zinc ions (green) were observed within 1 h after the ZnO NP treatment, and a slight increase in the zinc fluorescence (green) was observed in a time-dependent manner. Treatment with ZnOb NPs exhibited more potent fluorescence values than treatment with ZnOa NPs at 1 h. Moreover, significant overlaps (yellow) between cellular zinc ions and lysosomes were observed at all timepoints. Scale bar = 50µm. Magnification x600.


Read the original article


Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.